RESUMEN
Malaria transmission blocking (TB) vaccines (TBVs) directed against proteins expressed on the sexual stages of Plasmodium parasites are a potentially effective means to reduce transmission. Antibodies induced by TBVs block parasite development in the mosquito, and thus inhibit transmission to further human hosts. The ookinete surface protein P25 is a primary target for TBV development. Recently, transient expression in plants using hybrid viral vectors has demonstrated potential as a strategy for cost-effective and scalable production of recombinant vaccines. Using a plant virus-based expression system, we produced recombinant P25 protein of Plasmodium vivax (Pvs25) in Nicotiana benthamiana fused to a modified lichenase carrier protein. This candidate vaccine, Pvs25-FhCMB, was purified, characterized and evaluated for immunogenicity and efficacy using multiple adjuvants in a transgenic rodent model. An in vivo TB effect of up to a 65% reduction in intensity and 54% reduction in prevalence was observed using Abisco-100 adjuvant. The ability of this immunogen to induce a TB response was additionally combined with heterologous prime-boost vaccination with viral vectors expressing Pvs25. Significant blockade was observed when combining both platforms, achieving a 74% and 68% reduction in intensity and prevalence, respectively. This observation was confirmed by direct membrane feeding on field P. vivax samples, resulting in reductions in intensity/prevalence of 85.3% and 25.5%. These data demonstrate the potential of this vaccine candidate and support the feasibility of expressing Plasmodium antigens in a plant-based system for the production of TBVs, while demonstrating the potential advantages of combining multiple vaccine delivery systems to maximize efficacy.
Asunto(s)
Vacunas contra la Malaria/inmunología , Malaria Vivax/prevención & control , Proteínas Protozoarias/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Animales , Homólogo de la Proteína Chromobox 5 , Femenino , Inmunización Secundaria , Ratones Endogámicos BALB C , Plantas Modificadas Genéticamente , Plasmodium vivax , Proteínas Recombinantes/inmunología , Nicotiana , Vacunas de Subunidad/inmunología , Vacunas Sintéticas/inmunologíaRESUMEN
Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral delivery in the form of an edible vaccine. These vaccines are well suited to combat diseases where there is a clear antigen candidate, and where the costs of production or delivery for any current vaccine are prohibitive. Several academic and industrial research groups are currently investigating the use of plant-based vaccines in both humans and animals. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccine projects have given promising data in early phase trials targeting specific animal species. In this article the advantages offered by plant-based vaccines will be presented, progress on the most advanced vaccine candidates will be summarised, and the path ahead will be outlined. Although the focus of this paper is on the application of plant-based vaccines in the field of animal health, principally their use in domestic livestock, examples of the use of plant-based vaccines in the field of human health will also be discussed.
Asunto(s)
Plantas Modificadas Genéticamente , Plantas Medicinales , Vacunación/veterinaria , Vacunas , Administración Oral , Bienestar del Animal , Animales , Humanos , Plantas Modificadas Genéticamente/metabolismo , Investigación , Vacunas de ADN , Vacunas de Subunidad , Vacunas SintéticasRESUMEN
The use of plants for medicinal purposes dates back thousands of years but genetic engineering of plants to produce desired biopharmaceuticals is much more recent. As the demand for biopharmaceuticals is expected to increase, it would be wise to ensure that they will be available in significantly larger amounts, on a cost-effective basis. Currently, the cost of biopharmaceuticals limits their availability. Plant-derived biopharmaceuticals are cheap to produce and store, easy to scale up for mass production, and safer than those derived from animals. Here, we discuss recent developments in this field and possible environmental concerns.
Asunto(s)
Anticuerpos/genética , Plantas Comestibles , Plantas Modificadas Genéticamente , Vacunas Sintéticas/biosíntesis , Anticuerpos/química , Ingeniería Genética , Proteínas Recombinantes/biosíntesisRESUMEN
Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability, versatility and efficacy. Antigens expressed in corn are particularly advantageous since the seed can be produced in vast quantities and shipped over long distances at ambient temperature, potentially allowing global vaccination. We have expressed the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus at high levels in corn, and demonstrate that these antigens delivered in the seed elicit protective immune responses.
Asunto(s)
Proteínas de Escherichia coli , Plantas Modificadas Genéticamente/genética , Plantas Modificadas Genéticamente/inmunología , Vacunas Sintéticas/genética , Animales , Toxinas Bacterianas/genética , Toxinas Bacterianas/aislamiento & purificación , Biotecnología , Enterotoxinas/genética , Enterotoxinas/aislamiento & purificación , Ratones , Ratones Endogámicos BALB C , Plásmidos/genética , Rhizobium/genética , Transformación Genética , Virus de la Gastroenteritis Transmisible/genética , Virus de la Gastroenteritis Transmisible/inmunología , Vacunas Sintéticas/aislamiento & purificación , Proteínas Virales/genética , Proteínas Virales/aislamiento & purificación , Zea mays/genéticaRESUMEN
The Arabidopsis chlorophyll a/b binding protein (CAB) gene underexpressed 1 (cue1) mutant underexpresses light-regulated nuclear genes encoding chloroplast-localized proteins. cue1 also exhibits mesophyll-specific chloroplast and cellular defects, resulting in reticulate leaves. Both the gene underexpression and the leaf cell morphology phenotypes are dependent on light intensity. In this study, we determine that CUE1 encodes the plastid inner envelope phosphoenolpyruvate/phosphate translocator (PPT) and define amino acid residues that are critical for translocator function. The biosynthesis of aromatics is compromised in cue1, and the reticulate phenotype can be rescued by feeding aromatic amino acids. Determining that CUE1 encodes PPT indicates the in vivo role of the translocator in metabolic partitioning and reveals a mesophyll cell-specific requirement for the translocator in Arabidopsis leaves. The nuclear gene expression defects in cue1 suggest that a light intensity-dependent interorganellar signal is modulated through metabolites dependent on a plastid supply of phosphoenolpyruvate.
Asunto(s)
Arabidopsis/genética , Arabidopsis/metabolismo , Fosfatos/metabolismo , Fosfoenolpiruvato/metabolismo , Proteínas de Plantas/metabolismo , Arabidopsis/citología , Secuencia de Bases , Clorofila/biosíntesis , Clorofila A , ADN de Plantas/genética , Expresión Génica , Genes de Plantas , Luz , Datos de Secuencia Molecular , Mutación , Fenoles/metabolismo , Fenotipo , Fotosíntesis , Plastidios/genética , Plastoquinona/metabolismo , Ácido Shikímico/metabolismoRESUMEN
We report the isolation of a pgk- mutant strain of Aspergillus nidulans by means of a gene disruption strategy, and demonstrate that the pgk gene is located on chromosome VIII. The pgk- mutant conidiates poorly, will only grow on media supplemented with both a glycolytic and a gluconeogenic carbon source, and is inhibited by hexoses.
Asunto(s)
Aspergillus nidulans/enzimología , Fosfoglicerato Quinasa/genética , Aspergillus nidulans/genética , Mapeo Cromosómico , Cromosomas Fúngicos , Diploidia , Genes Fúngicos , Vectores Genéticos , Haploidia , Mutación , Penicillium chrysogenum/genética , Fenotipo , Transformación GenéticaRESUMEN
Cholera toxin and the related heat-labile enterotoxin (LT) produced by Escherichia coli consist of a holotoxin of one A subunit and five B subunits (AB5). Here we investigate the domains of the A subunit (EtxA) of E. coli LT which influence the events of B-subunit (EtxB) oligomerization and the formation of a stable AB5 holotoxin complex. We show that the C-terminal 14 amino acids of the A subunit comprise two functional domains that differentially affect oligomerization and holotoxin stability. Deletion of the last 14 amino acids (-14) from the A subunit resulted in a molecule that was significantly impaired in its capacity to promote the assembly of a mutant B subunit, EtxB191.5. In contrast, deletion of the last four amino acids (-4) from the A subunit gave a molecule that retained such a capacity. This suggests that C-terminal residues within the -14 to -4 region of the A subunit are important for promoting the oligomerization of EtxB. In addition, we demonstrate that the truncated A subunit lacking the last 4 amino acids was unable to form a stable AB5 holotoxin complex even though it promoted B-subunit oligomerization. This suggests that the last 4 residues of the A subunit function as an "anchoring" sequence responsible for maintaining the stability of A/B subunit interaction during holotoxin assembly. These data represent an important example of how intermolecular interactions between polypeptides in vivo can modulate the folding and assembly of a macromolecular complex.
Asunto(s)
Toxinas Bacterianas/química , Enterotoxinas/química , Proteínas de Escherichia coli , Escherichia coli/metabolismo , Secuencia de Aminoácidos , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Secuencia de Bases , Enterotoxinas/genética , Enterotoxinas/metabolismo , Regulación Bacteriana de la Expresión Génica , Genes Bacterianos , Sustancias Macromoleculares , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Biosíntesis de Proteínas , Conformación Proteica , Desnaturalización Proteica , ARN Mensajero/genética , Proteínas Recombinantes , Secuencias Reguladoras de Ácidos Nucleicos , Relación Estructura-Actividad , Transcripción GenéticaRESUMEN
A functional analysis of the Aspergillus nidulans 3-phosphoglycerate kinase pgk promoter was undertaken using gene fusions to the lacZ gene of Escherichia coli, and introducing these into a beta-galactosidase-deficient strain of A. nidulans. Expression of a particular gene fusion in transformed strains depends upon the site of integration of the vector into the genome, and when specifically targeted to the catabolic quinate dehydrogenase qutE (selective marker) locus is directly proportional to its copy number. The analysis of transformed strains with single copies of pgk promoter deletion--lacZ fusions at the qutE locus identified three constitutive, positively acting sequence elements in the pgk gene. Sequence located between -161 and -120 nucleotides relative to the transcript start site +1, and including an element with a seven-out-of-eight nucleotide match (AAGCAAAT; -131 to -124) to the consensus eukaryotic octamer sequence ATGCAAAT, is essential for expression, and deletion of the complete 41-nucleotide sequence abolishes transcription. Sequence encompassing codons 14 to 183 and including the two introns of pgk contributes approximately one-third of the total activity, and far upstream sequence 5' to position -638 contributes approximately a further one-third total activity. In addition, sequence located -638 to -488 nucleotides, which includes an apparent consensus feature of A. nidulans glycolytic genes, affects carbon source-dependent regulation of expression. This region is required for an approximately 50% increase in pgk expression when A. nidulans is grown on gluconeogenic compared with glycolytic carbon sources.